Clinical trial
A Multicenter Clinical Study to Determine the Performance Characteristics of the MassPLEX Factor II and Factor V Leiden Genotyping Test in Patients With Suspected Thrombophilia
NCT01835483 is registered in ClinicalTrials.gov with Sequenom, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Clinical Study to Determine the Performance Characteristics of the MassPLEX Factor II and Factor V Leiden Genotyping Test in Patients With Suspected Thrombophilia
- Lead sponsor
- Sequenom, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- July 31, 2013
- Enrollment
- 867 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
factor ii, factor v leiden, thrombosis